ACUTE MEGAKARYOBLASTIC LEUKEMIA IN CHILDREN AND ADOLESCENTS - A RETROSPECTIVE ANALYSIS OF 24 CASES

被引:47
作者
RIBEIRO, RC
OLIVEIRA, MSP
FAIRCLOUGH, D
HURWITZ, C
MIRRO, J
BEHM, FG
HEAD, D
SILVA, MLM
RAIMONDI, SC
CRIST, WM
KRANCE, R
机构
[1] Department of Hematology-Oncology, University of Tennessee, Rio de Janeiro
[2] Department of Pathology and Laboratory Medicine, institutionname, Rio de Janeiro
[3] Departments of Biostatistics, University of Tennessee, Rio de Janeiro
[4] University of Tennessee, Memphis College of Medicine, Memphis, TN
[5] National Institute of Cancer, Rio de Janeiro
[6] Department of St. Jude Children's, Research Hospital, Memphis, TN
关键词
ACUTE NONLYMPHOCYTIC LEUKEMIA; MEGAKARYOBLASTIC; FAB; M7; CHILDREN;
D O I
10.3109/10428199309148552
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In order to characterize the clinical, cytogenetic, and outcome features of childhood acute megakaryoblastic leukemia (AMKL), we reviewed 24 cases; 14 were identified among 150 consecutive newly diagnosed acute myelogenous leukemia (AML) patients at St. Jude Children's Research Hospital, and 10 were cases referred to the National Institute of Cancer in Rio de Janeiro, Brazil. There were 5 Down syndrome patients and one patient with chronic myeloid leukemia (Ph+) in blastic crisis. Twelve patients had significant hepatosplenomegaly. Leukemic cell morphology and cytochemistry were consistent with the M7 classification in 17 cases, and all cases tested expressed megakaryocytic surface antigens. AMKL patients were significantly younger than other AML patients (P = 0.0001) and had poorer responses to therapy (P = 0.03, univariate analysis only). Ten of 24 failed induction, and only 5 are disease-free at 6 months to 4.5+ years. We conclude that AMKL usually affects young children, frequently producing marked organomegaly. It comprises approximately 10% of pediatric AML cases, and responds poorly to intensive AML therapies.
引用
收藏
页码:299 / 306
页数:8
相关论文
共 51 条
  • [1] Von Boros J., Korenyi A., Über einen fall von akuter megakaryoblastenleukämie, zugleich einige bemerkun-gen zum problem des akuten leukämie, Z. Klin. Med., 118, pp. 681-718, (1931)
  • [2] Bennett J.M., Catovsky D., Daniel M.-T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C., Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): a report of the French-American-British Cooperative Group, Ann. Intern. Med., 103, pp. 460-462, (1985)
  • [3] Chan B.W.B., Flemans R.J., Zbinden G., Acute leukemia with megakaryocytic predominance, Cancer., 28, pp. 1343-1349, (1971)
  • [4] Den Ottolander G.J., Velde J., Brederoo P., Geraedts J.P.M., Slee P.H.T., Willemze R., Zwaan F.E., Haak H.L., Muller H.P., Bieger R., Megakaryoblas-tic leukaemia (acute myelofibrosis): a report of three cases, Br. J. Haematol., 42, pp. 9-20, (1979)
  • [5] Bevan D., Rose M., Greaves M., Leukaemia of platelet precursors: diverse features in four cases, Br. J. Haematol., 51, pp. 147-164, (1982)
  • [6] Huang M.-J., Li C.Y., Nichols W.L., Young J.-H., Katzmann I.A., Acute leukemia with megakaryocytic differentiation: a study of 12 cases identified immunocyto-chemically, Blood, 64, pp. 427-439, (1984)
  • [7] San Miguel J.F., Gonzalea M., Canizo M.C., Ojeda E., Orfao A., Caballero M.D., Moro M.J., Fisac P., Borrasca A.L., Leukemias with megakaryoblastic involvement: clinical, hematologiC., and immunologic characteristics, Blood, 72, pp. 402-407, (1988)
  • [8] Ruiz-Arguelles G.J., Marin-Lopez A., Lobato-Mendizabal E., Kuiz-Arguelles A., Nichols W.L., Katzman J.A., Acute megakaryoblastic leukaemia: a prospective study of its identification and treatment, Br. J. Haematol., 62, pp. 55-63, (1986)
  • [9] Breton-Gorius J., Reyes F., Duhamel G., Majman A., Gorin N.C., Megakaryoblastic acute leukemia: identification by the ultrastructural demonstration of platelet per-oxidase, Blood, 51, pp. 45-59, (1978)
  • [10] Williams D.L., Harris A., Williams K.J., Brosius M.J., Lemonds W., A direct bone marrow chromosome technique for acute lymphoblastic leukemia, Cancer Genet. Cytogenet., 13, pp. 239-257, (1984)